Program Description: 

This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of urologic disorders into clinical practice. Speakers will utilize their personal, institutional and evidence-based experience to address patient health care conditions requiring clinical and surgical treatment.  Speakers will also utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of urologic disease and other aspects of urologic  patients’ general health. Evidence-based data regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to urology within the broader scope of American health care will be discussed.  There are varying degrees to individuals’ knowledge regarding clinical and urologic treatments.  While individuals may be aware of varied treatment within the urologists’ armamentarium it is beneficial to address the topics from an evidence-based approach.

 
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

 

Target audience: 
  • Urology Faculty
  • Allied Healthcare Providers
  • Community Physicians
Learning objectives: 
At the conclusion of this activity, I will be able to:
A. Be familiar with and able to present to the audience new advancements in BPH management from a surgical/procedural standpoint.
B. To understand the best management strategies from a medical/pharmacological standpoint for BPH based upon the literature/current studies.
C. To discuss and understand the epidemiology, etiology, and pathophysiology associated with BPH and be able to educate an audience on the impact of this chronic disease on an overall global health picture.
Faculty & credentials: 
Planning Committee:
Ken Jacobsohn, MD
William See, MD

 

 

All persons in control of content have no relevant financial relationships to disclose with the exception of the following person: 
 

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

CME Coordinator Contact Information

Name: 
Tammy Janik
Phone number: 
+1 (414) 955-0880
Series date: 
Tuesday, January 1, 2019 - 12:00am to Tuesday, December 31, 2019 - 10:00am
Series location: 
HUB- 6th floor ---room 6520
8701 Watertown Plank Road
HUB
Milwaukee, WI 53226
United States